Release date: January 17, 2022
Expiration date: January 17, 2024
Estimated Time of Completion: 15 minutes
Description
The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
Learning Objectives
- Summarize the challenges in assessing transplant feasibility and current transplant strategies in older MDS patients.
Target Audience
The virtual satellite symposium is designed for an international audience including medical oncologists, hematologists, clinical and translational researchers, and other physicians and allied health care professionals treating patients with MDS, AML and myeloid malignancies. In addition, members of patient advocacy groups will benefit from this program.
Accreditation
In support of improving patient care, this activity has been planned and implemented by Cleveland Clinic Center for Continuing Education and Aplastic Anemia & MDS International Foundation. Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 0.25 ANCC contact hours.
American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations
Activity Director and Faculty
Activity Director
Bhumika Patel, MD
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH
Sudipto Mukherjee, MD, PhD, MPH
Department of Hematology and Medical Oncology
Taussig Cancer Institute
Cleveland Clinic
Cleveland, OH
Faculty
Mark Juckett, MD
Medical Director of the Cell, Gene, and Immunotherapy Clinical Trial Office
Univerity of Minnesota Medical School
Minneapolis, MN
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty member has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:
| Sudipto Mukherjee, MD |
| Aplastic Anemia and MDS International Foundation |
Honorarium - Activity Director of ASH Friday Satellite Symposium 2020 |
| Eusa Pharma |
Consulting
Advisor or review panel participant
Teaching and Speaking |
| Novartis |
Consulting
Research / Independent Contractor
Advisor or review panel participant |
| McGraw Hill |
Honoraria - Editor of Hematology Oncology Board Review (ongoing) |
| Bristol-Myers Squibb Co. |
Advisor or review panel participant
Honoraria |
| Celgene Corporation |
Board Membership
Consulting
Research / Independent Contractor
Advisor or review panel participant
Research Funding - non-therapeutic investigator trials. Formerly Celgene (now BMS) |
The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Mark Juckett, MD
Acknowledgement
The Aplastic Anemia and MDS International Foundation and Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this internet enduring activity from:
Alexion Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc.
Ascentage Pharma Group, Inc.
Biocryst Pharmaceuticals Inc.
Bristol-Myers Squibb
Geron Corporation
Taiho Oncology
Takeda Oncology
|
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Taussig Cancer Institute and Aplastic Anemia & MDS International Foundation.
